VR Logo

Morepen Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1984

Chairman: Sushil Suri

Managing Director: Sushil Suri

Group: Morepen

Listing: NSE: MOREPENLAB, BSE: 500288

Headquarters: Solan Dist, Himachal Pradesh

Website: www.morepen.com

Key Facts

Market cap: R 1,052.59 Cr

Revenue (TTM): R 853.07 Cr

Earnings (TTM): R 33.59 Cr

Cash: R 32.23 Cr

Total Debt: R 11.94 Cr

Promoters' ownership: 34.54%

Liquidity: High

52 Week range: R 7.20 - 34.95

Face value: R2.00

Shares outstanding: 44,98,26,203

10 Years Aggregate:

  • CFO: 334.35 Cr
  • EBITDA: 419.90 Cr
  • Net Profit: -2.92 Cr

Stock Performance

Time Period Morepen Laboratories S&P BSE Healthcare S&P BSE Small Cap
YTD50.4824.01-6.68
1 month10.383.257.93
3 months48.5712.7524.77
1 Year33.8828.69-7.17
3 Years7.284.54-7.13
5 Years12.37-0.732.17
10 Years11.7511.243.13
As on 13-Jul-2020
Year Morepen Laboratories S&P BSE Small Cap S&P BSE Healthcare
2019-29.48-6.85-3.55
2018-40.53-23.41-5.89
201783.5459.640.49
2016-48.931.77-12.88
2015296.326.7615.06
2014110.4769.2447.43
20137.89-11.2322.55

Review & Analysis